BofA Securities downgraded Axcelis Tech from Buy to Neutral
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/21/2025 | $50.00 | Buy → Neutral | B. Riley Securities |
| 2/12/2025 | Outperform → Mkt Perform | William Blair | |
| 11/8/2024 | Buy → Hold | The Benchmark Company | |
| 5/3/2024 | $130.00 | Hold → Buy | Craig Hallum |
| 12/15/2023 | Buy → Neutral | BofA Securities | |
| 9/15/2023 | $225.00 | Buy | BofA Securities |
| 8/4/2023 | $140.00 → $175.00 | Buy → Hold | Craig Hallum |
| 6/14/2023 | Buy → Hold | Needham |
BEVERLY, Mass., April 17, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the first quarter 2025 before the opening of the market on Tuesday, May 6, 2025. The Company will host a call the same day to discuss the results at 8:30 a.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registering as a participant here: https://register-conf.media-server.com/
Q4 Highlights: Revenue of $252.4 millionOperating Margin of 21.6%Diluted earnings per share of $1.54BEVERLY, Mass., Feb. 10, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the fourth quarter and full year ended December 31, 2024. For the full year 2024, the Company reported revenue of $1.02 billion, compared with $1.13 billion for the full year 2023. Systems revenue for the year was $782.6 million, compared to $883.6 million in 2023. Operating profit was $210.8 million in 2024, compared to $265.8 million in 2023. Net income
BEVERLY, Mass., Jan. 23, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the fourth quarter and full year 2024 after market close on Monday, February 10, 2025. The Company will host a call to discuss the results for the fourth quarter and full year 2024 on Tuesday, February 11, 2025, at 8:30 a.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registeri
B. Riley Securities downgraded Axcelis Tech from Buy to Neutral and set a new price target of $50.00
William Blair downgraded Axcelis Tech from Outperform to Mkt Perform
The Benchmark Company downgraded Axcelis Tech from Buy to Hold
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
8-K - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
DEF 14A - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
8-K - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
BEVERLY, Mass., April 24, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that it will be a sponsor for the Advanced Semiconductor Manufacturing Conference (ASMC) on May 5-8, 2025, at the Hilton Albany, in Albany, New York. This event brings together manufacturers, equipment and materials suppliers, and academia to solve manufacturing challenges with innovative strategies and methodologies. Axcelis will present in Session 5: Contamination Free Manufacturing:
BEVERLY, Mass., April 17, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the first quarter 2025 before the opening of the market on Tuesday, May 6, 2025. The Company will host a call the same day to discuss the results at 8:30 a.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registering as a participant here: https://register-conf.media-server.com/
President and CEO Russell Low will Present Keynote Speech at CS Asia BEVERLY, Mass., March 17, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that it will be the Diamond Sponsor for the Compound Semiconductor Asia Conference (CS Asia) 2025. The event is being held in conjunction with SEMICON China 2025 on March 25-27, 2025, at the Kerry Hotel in Pudong, Shanghai. Axcelis' President and CEO, Russell Low, will present an opening Keynote Speech at the event. I
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
The Company Announces Planned Retirement of Doug Lawson, Executive Vice President of Corporate Marketing and Strategy BEVERLY, Mass., June 27, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today named David Ryzhik as Senior Vice President of Investor Relations and Corporate Strategy, assuming responsibility for the role in July 2024. The Company also announced the retirement of Doug Lawson, Executive Vice President of Corporate Marketing and Strategy. Mr. Lawson plans to retire in July 2024 and will remain as a Senior Advisor through July 2025.
BEVERLY, Mass., April 2, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today a shipment of the Company's Purion EXE™ SiC high energy implanter as well as a successful Purion H200™ SiC medium energy implanter evaluation closure at leading power device chipmakers located in Japan. The systems will be used for 150mm and 200mm production of silicon carbide power devices supporting automotive, industrial, energy, and other power intensive applications. Greg Redinbo,
SOLANA BEACH, Calif., July 15, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global therapy-enabling platform company providing navigation and delivery to the brain, is pleased to announce that Lynnette C. Fallon has been appointed to the Company's Board of Directors effective immediately. Ms. Fallon will also become a member of the Company's Audit Committee. Ms. Fallon is the Executive Vice President, HR/Legal, General Counsel and Secretary of Axcelis Technologies, Inc. (NASDAQ:ACLS), a provider of equipment and service solutions for the semiconductor manufacturing industry, with locations in eight countries. Ms. Fallon has held her current position sin